Anthropic is operating a lab that conducts biology experiments
Anthropic is operating a lab that conducts biology experiments
Anthropic 正在运营一家进行生物学实验的实验室
Anthropic has confirmed that it has a wet biology lab where it can use its AI models to run physical experiments. AI leaders have been promising that AI is the key to curing human disease. Dario Amodei opined just last week: “I believe that AI could cure most major diseases in the next 5–10 years.” Anthropic 已证实其拥有一家湿实验室（wet lab），可以在此利用其 AI 模型进行物理实验。AI 行业的领军人物一直承诺，AI 是治愈人类疾病的关键。Dario Amodei 上周刚刚表示：“我相信 AI 可以在未来 5 到 10 年内治愈大多数重大疾病。”
To do that, an LLM would have to have methods to test its theories in real life. “We believe that to do biology, the final test is still, and will be for a while, in real lab work,” Anthropic’s head of life sciences, Eric Kauderer-Abrams told Reuters. “We absolutely are doing that today.” 要做到这一点，大语言模型（LLM）必须具备在现实生活中验证其理论的方法。Anthropic 生命科学负责人 Eric Kauderer-Abrams 对路透社表示：“我们认为，要进行生物学研究，最终的测试仍然是，并且在未来一段时间内仍将是现实中的实验室工作。我们现在绝对正在这样做。”
He added that the lab operates like most biotech labs: Anthropic conducts some research there while also working with externals partners. This news probably shouldn’t be shocking. Anthropic bought Coefficient Bio, a stealth AI biotech, in April. 他补充说，该实验室的运作方式与大多数生物技术实验室一样：Anthropic 在那里进行部分研究，同时也与外部合作伙伴开展合作。这个消息或许并不令人震惊。Anthropic 在今年 4 月收购了一家处于隐身状态的 AI 生物技术公司 Coefficient Bio。
It declined to say what the wet lab is working on, except that it’s not focused on drug discovery. Anthropic doesn’t want to give the appearance of competing with the pharma industry, where it has numerous major customers and partners. (For instance, it just announced a deal to work with Novo Nordisk on joint drug discovery.) 该公司拒绝透露该湿实验室的具体研究方向，仅表示其重点不在药物研发。Anthropic 不希望给人留下与制药行业竞争的印象，因为该行业拥有其众多主要客户和合作伙伴。（例如，它刚刚宣布与诺和诺德达成协议，共同进行药物研发。）
Anthropic has already faced backlash for launching products perceived to compete with those of its customers. To that end, Anthropic also launched a Life Sciences Verification Program this week, to give vetted bio researchers access to its most powerful models. Anthropic 此前因推出被认为与其客户产品存在竞争关系的产品而面临强烈抵制。为此，Anthropic 本周还启动了一项“生命科学验证计划”（Life Sciences Verification Program），旨在让经过审查的生物研究人员能够使用其最强大的模型。
But the world is still reeling from the resignation of Anthropic researcher Jacob Coxon, who warned that “the people building AI earnestly believe that it could kill us all by the end of the decade.” Anthropic’s own alignment lead gave the odds at greater than 10% that AI could exterminate humanity within the next decade. 然而，世界仍未从 Anthropic 研究员 Jacob Coxon 的辞职风波中平复，他曾警告称：“开发 AI 的人们真诚地相信，AI 可能会在本世纪末之前杀死我们所有人。”Anthropic 自己的对齐负责人甚至认为，AI 在未来十年内灭绝人类的可能性超过 10%。
The fervor has grown so intense that CEO Dario Amodei published a post last weekend calling on the industry to slow down and institute self-regulation. He has repeatedly called bioterrorism one of AI’s biggest risks. 这种焦虑情绪愈演愈烈，以至于首席执行官 Dario Amodei 上周末发表文章，呼吁行业放慢脚步并建立自律机制。他多次将生物恐怖主义列为 AI 最大的风险之一。
The juxtaposition of these dire warnings and the wet lab has not gone unnoticed in the tech industry. As investor and AI coding startup founder Chamath Palihapitiya posted on X, somewhat tongue-in-cheek: “The group behind such hits as: “We’re All Going To Die” and “Regulate Me Now” are building a wet lab in SF. I do not recommend this.” 这些严峻的警告与湿实验室并存的现状，在科技界引起了关注。正如投资者兼 AI 编程初创公司创始人 Chamath Palihapitiya 在 X 上半开玩笑地写道：“这群曾制造出‘我们都要完蛋了’和‘快来监管我吧’等热门话题的人，现在正在旧金山建立一个湿实验室。我不推荐这样做。”